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Glutathione (GSH) instability leading to its depletion, and enhanced lipid peroxidation, are associated 
with the pathogenesis, progression and therapy of many diseases / disease conditions – including sickle 
cell disease. In this study, the effects of two antioxidants, ascorbic acid and α - tocopherol, on GSH 
instability and lipid peroxidation were assessed before inducing oxidative stress with 
acetylphenylhydrazine (APHZ) (Pre-APHZ), post APHZ, and post – APHZ followed with ascorbic acid and 
α - tocopherol respectively. The mean pre-APHZ GSH concentration of 26 + 2.32 mg/100ml was 
significantly (p < 0. 05) reduced to 13 + 1.98mg/100ml post – APHZ. This post – APHZ value was 
insignificantly (p > 0.05) elevated to 16 + 1.82 mg/100ml when treated with ascorbic acid, while α - 
tocopherol significantly (p < 0.05) elevated it to 22 + 2.24 mg/100ml. APHZ significantly (p < 0.05) elevated 
the level of lipid peroxidation (MDA) from 210.91 + 23.43 nmol/hr (pre-APHZ) to 284 + 31.00 nmol/hr post-
APHZ. Both ascorbic acid and α - tocopherol did not reduce this post – APHZ lipid peroxidation level 
significantly (p > 0.05) as the post APHZ + ascorbic acid and post – APHZ + α - tocopherol levels of MDA 
remained at life – threatening levels of 266.70 + 31.00 nmol/hr and 238.50 + 26.37 nmol/hr respectively. In 
this study, α - tocopherol was a better antioxidant than ascorbic acid but it appears that elevation of GSH 
level per se is not enough to arrest drug – induced lipid peroxidation in sickle cell patients and 238.50 + 
26.37 nmol/hr respectively. In this study, α - tocopherol was a better antioxidant than ascorbic acid but it 
appears that elevation of GSH level per se is not enough to arrest drug – induced lipid peroxidation in 




Introduction    
 
Glutathione, a tripeptide of glutamic acid, cysteine 
and glycine (Panela et al., 2005), is synthesized in 
the cytosol as part of the ϒ- glutamylcysteine cycle 
of GSH metabolism (Voet and Voet, 1994). 
Glutathione (GSH), a tripeptide of glutamic acid, 
cysteine and glycine (Pamela, et al, 2005), is 
synthesized in the cytosol as part of the µ – 
glutamy/ cycle of GSH metabolism (Voet and Voet, 
1994). Many physiological processes, especially in 
the highly oxidizing environment of the erythrocyte, 
oxidize GSH to GSSG, but the cell is able to 
maintain a GSH: GSH: GSSG ratio of over 100, 
which permits GSH to function as an intracellular 
reducing agent, through the action of glutathione 
reductase (Pamela et al., 2005; Voet and Voet, 
1994). By cycling between the reduced thiol forms 
(GSH) and the oxidized form (GSSG), glutathione, 
which is usually present at high levels (~ 5nM) in 
animal cells, serves as a sulphydryl (SH) buffer 
(Stryer, 2000). Erythrocyte membranes, thiols (e.g. 
cysteine, cysteinylglycine, µ – glutamylcysteine), 
thiol – containing enzymes, and other proteins (e.g. 
haemoglobin), are maintained in the reduced state 
by GSH because they are not subject to direct 
reduction by NADPH (Griffith, 1991).It has been 
established that the α – glutamyl /cysteine cycle 
serves as a vehicle for the energy –driven transport 
(group transfer) of amino acids into cells through 
the synthesis and breakdown of GSH (Voet and 
Voet, 1994) GSH is also conjugated to drugs in the 
second phase of xenobiotic transformations, but 
unlike other conjugating agents, it has no identified 
nucleotide intermediate (De Leve and Kaplowitz, 
1991). In the synthesis of peptidoleukotrienes, GSH 
is the source of the SH group added to leukotriene 
A4, an epoxide, to form the first of the leukotrienes, 
leukotriene C4 (Voet and Voet 1994). 
Peroxidative modification of unsaturated 
phospholipids, free fatty acids, glycolipids, 
lipoproteins (especially low-density lipoprotein), and 
cholesterol, is triggered by free radicals (e.g. O2, 
OH, OONO-) non-free radical species (e.g. O2, O3, 
O1), and oxidant drugs (Kappus and Sies 1981). 
Lipid peroxidation occurs in a variety of cells and 
tissues, including microsomal membranes, 
peroxisomes, mitochondria, lysosomes, and 
erythrocyte membranes (Monaharan et al., 2002). 
The intermediates or products of lipid peroxidation, 
mainly hydroperoxides, ketones, aldehydes and 
diadehydes, cause covalent intra – and inter – 
molecular bonds/cross-linking with proteins and 
other biomolecules (Siroev and Makarova, 1989), 
and this calls for cytoprotection to avert apoptotic 
death (Lee, et al, 2002). Accordingly, oxidative 
stress engendered by an imbalance between the 
rate of production of free radicals and anti-
peroxidative defences has been implicated in the 
pathogenesis of many diseases, ageing, and 
disease complications – including sickle cells 
syndrome (Ho, et al, 2007). The primary line of 
defence for counteracting free radical damages is a 
system of enzymes – glutathione peroxidase (GPx), 
superoxide dismutase (SOD), and catalase; GPx, 
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for example, catalyzes the reaction of 
hydroperoxides swith GSH to form GSSG and 
either an alcohol or water (Ho, et al, 2006). The 
secondary line of defence against free radical 
damages is provided by the antioxidants/free radical 
scavengers (Bilgin-Karabulut, et al, 2001), About 
400 antioxidants have been identified, but the best 
known /studied are GSH,α - tocopherol (Vit. E), 
ascorbic acid (Vit. C) retinol (Vit. A), carotenoids 
(pro-vit. A), carotenoids (pr0-vit.A), ubiquinol and 
uric acid (Van – Acker, et al, 2000). In spite of the 
roles played by free radicals in pathology, they are 
however necessary for the maturation of cellular 
structures, and released by macrophages and 
neutrophils to destroy invading pathogenic microbes 
(Bagchi and Puri, 1998).  
 
Materials and Methods          
 
A total of thirty (30) sickle cell patients between the 
ages of 10 and 25 years was used for this study. All 
the patients were attending regular checkups at the 
Federal Medical Centre, Abakaliki, and were not 
having crises at the time of collecting their blood 
samples. They all consented to the requests to use 
their blood for research purposes only. Five 
milliliters (5ml) of venous blood were drawn from 
each patient – 3ml for GSH and 2ml for lipid 
peroxidation (TBARs) assays respectively. 
Oxidative stress was induced for each assay with 
5mg of acetyphenythydrazine (APHZ) per ml of 
whole blood. Each parameter (GSH and TBARs) 
was measured pre-APHz treatment, post – APHZ, 
and post – APHZ follow by a ascorbic acid and α - 
tocopherol in different assay test tubes.  
Glutathione determination was done 
according to the acid – citrate – D – glucose (ACD) 
method of Beutler (196). Five milliliters 95ml) of 
venous blood were drawn into 1ml of an aqueous 
ACD solution containing 16. 0g of sodium citrate, 
4.8g of citric acid, and 29.5g of glucose per litre. 
5mg of APHZ were added to the test tube, mixed, 
shaken to ensure thorough oxygenation, and 
incubated for 2hours at 370C in a water bath. At the 
end of the incubation period, 2ml of distilled water 
were added. Five minutes later, 5ml of 3% glacial 
metaphosphoric acid (equivalent to 35% H2 PO3) 
were added with agitation, followed by 3g of NaCI. 
The reaction mixture was shaken. The mixture was 
filtered, and 2ml of the filtrate added to 6ml of 
saturated NaCI solution in a 25 – mm cuvette, while 
the solution was equilibrated at 20 - 220C.1ml each 
of 2% sodium nitroprusside and 0.67 M NaCN – 5M 
Na2C03 were added to develop colour. A 
spectrophotometer reading was made at 525nm 
within one minute and the values read off from a 
standard curve.  
Erythrocyte lipid peroxidation, estimated as 
the rate of malondialdehyde (MDA) formation per 
unit time (nmol/hour), was determined according to 
the method described by Siroev and Makarova 
(1989). 2ml of oxalated (1.34%) blood were placed 
in a centrifuge tube and centrifuged for 10 minutes 
at 3000 x g. The supernatant was carefully drawn 
off with a Pasteur pipette. The erythrocyte residue 
was washed three consecutive times with three 
volumes of 0.9% NaCI, and centrifuged again for 10 
minutes at 3000x g to further precipitate the 
crythrocytes. Next, 0.50ml of the erythrocyte 
precipitate and an equal volume of distilled water 
were placed in a clean centrifuge tube and allowed 
to stand for 30 minutes to allow complete 
haemolysis to occur. This mixture was centrifuged 
for 30 minutes at 3000 x g and, with a Pasteur 
pipette, the supernatant, together with grey-
coloured intermediate layer of the haemolyzed 
erythrocyte membrances were transferred into a 
clean test tube. Two test tubes were labeled 
samples 1 and 2 respectively. In tube 1 were placed 
0.3ml of 4 x 10-5M Mohr salt solution, 0.3ml of 
0.04M tris-HCI buffer, 0.3ml of 2.6mM ascorbic acid 
solution, and 0.1ml of erythrocyte membrane 
suspension. To tube 2, the control, was added 
0.3ml of Mohr solution, 0.3ml of tris-HCI buffer, 
0.3ml of ascorbic acid solution, 0.1ml of erythrocyte 
membrane suspension, and 1ml of 40% 
trichloroacetic acid solution, which was added 
immediately. The two test tubes were placed in a 
water bath at 370C for 20 minutes. Thereafter, the 
reactions in both tubes were stopped with 1ml of 
trichloroacetic acid solution. The samples were 
further centrifuged for 15 minutes at 3000 x g, the 
supernatant liquids were decanted into separate 
clean test tubes, and 1ml of 0.8% thiobarbituric acid 
added to each tube. The tubes were placed in a 
boiling water bath for 10 minutes and then cooled in 
ice – cold water. The absorbance in tube 1 was 
measured against the control (tube 2 ) at 532nm 
and read off from a  standard curve.  
 
Results and Discussion    
 
Most of the complications of sickle cell syndrome 
are traceable to repeated cycles of 
oxygenation/deoxygenation which result in 
irreversible membrane damage (USDHHS, 1989). 
Its exacerbation is in turn linked to low GSH levels 
of erythrocytes and the concomitant low level of 
pentose phosphate pathway – derived NADPH. The 
consequence, membrane lipid peroxidation among 
others, leads to both intravascular and macrophage 
– mediated splenic haemolyses which ultimately 
precipitate haemolytic crisis (Satyen et al., 2006).  
The low mean GSH level of 26 + 2.32 mg 
/100ml pre – APHZ treatment (Table 1) when 
compared with 40.00 mg/100ml in non – sickle cell 
individuals (USDHHS, 1989), is indicative of 
subsisting haemolysis that characterizes sickle cell 
anaemia because GSH is needed for the 
maintenance of red cell integrity (Pamel et al., 
2005). Further depletion of this pre-APHZ mean 
GSH level to 13 + 1.98 mg/100ml post – APHZ was 
strongly significant (p < 0.05). This drastic reduction 
in GSH level could either be due to low G6PD 
activity in the erythrocytes of such patient leading to 
a lower reductant (NADPH) level, or there were high 
levels of endogenously generated redox species, 
particularly reactive oxygen and nitrogen species 
which are known to deplete red cell GSH (HO, et al, 
2007).  
If the latter reason is correct, it implies that 
the reactive species so generated overwhelmed the 
primary enzymes line of defence for counteracting  




Table 1: Mean glutathione (GSH) and malondialadehyde (MDA) levels of erythrocytes before APHZ 
treatment, post APHZ treatment, and post – APHZ + ascorbic acid and α - tocopherol  
Parameter Pre-APHZ Treatment 
 
Post-APHZ Treatment Post-APHZ + 
Ascorbic acid 
Post – APHZ + α - 
tocopherol 
GSH (mg/100ml) 26 + 2.32 13 + 1.98 16 + 1.82 22 + 2.24 
MDA (nmo1hr-1) 210.91 + 23.43 284 + 31.00 266. 70 + 31.1.00 238. 50 + 26. 37 
 
free radical damages, especially glutathione 
peroxidase which catalyzes the reaction of 
hydroperoxides with GSH to form GSSG and either 
an alcohol or water which is a further source of free 
radicals (Ho, et al, 2006). That the GSH depletion of 
the erythrocytes was free – radical mediated was 
borne out by the fact that ascorbic acid and α - 
tocopherol, the two antioxidants which should be 
secondary lines of defence against free radical 
damages (Bilgin – Karabulut, et al, 2001) elevated 
the mean GSH levels from the post – APHZ level of 
13 + 1.98 mg/100ml to 16 + 1.82 mg / 100ml and 22 
+ 2.24 mg/100ml respectively. compared with the 
known mean GSH level of 40 mg/100ml in non – 
sickle cell subjects (USDHHS, 1989), the mean 
levels in the cells studied were still too low to 
maintain the red cells membrane integrity. Over 
whelming level of free radicals with a concomitant
depletion of red cell GSH level must be a major 
contributory factor to the massive haemohysis seen 
in sickle cell anaemia.  
 
At baseline, ie, pre-APHZ, the mean MDA 
level of the erythrocytes studied was very high 
(210.91 + 23.43 nmol/hr) when compared with the 
level found in non-sickle cell subjects under the 
same condition, i.e., in the absence of an oxidant 
stressor (Aloh, 2008). As demonstrated by Klings 
and Farber (2001), this is likely to be due to the 
presence of lipid peroxyl radicals which are known 
to be involved in the pathogenesis of sickle cell 
complications, especially in the presence of oxidant 
drugs. This is also consistent with the human 
studies by Aslan et al. (2000), which demonstrated 
high levels of TBARs in sickle erythrocytes at 
baseline. The significant (p < 0.05) elevation of the 
mean MDA level to 284 + 31.00 nmol/hr post – 
APHZ treatment was consistent with the significant 
(p < 0. 05) depletion of the man GSH levels of the 
red cells post – APHZ. In other words, the free 
radicals generated by APHZ in addition to the 
endogenously generated ones markedly depleted 
the red cell GSH and exacerbated the lipid 
peroxidation observed as high MDA levels. 
Although both ascorbic acid and α - tocopherol 
down-regulated the MDA levels in the APHZ – 
treated erythrocytes, they (the MDA levels) still 
remained at life – threatening levels.  Hence, as a 
consequence of free – radical medicated depletion 
of the red cell GSH levels, lipid peroxidation was 
aggravated, the iron in haemoglobin was 
maintained in the ferric (Fe3+) state that could not 
transport oxygen to the tissues (Stryer, 2000), and 
haemohysis occurred. This result strongly indicated 
that much of the haemolysis seen  in sickle cell 
anaemia is intravascular since this study was in 
vitro.  
This study has demonstrated that the GSH 
and MDA levels of the erythrocytes of sickle cell 
patients are lower and higher respectively, than  
 
those of “normal” (non-sickle cell) subjects even in 
the absence of oxidative stress. It further 
demonstrated that oxidant drugs deplete red cell 
GSH levels and consequently aggravate lipid 
peroxidation to cause the massive haemolysis 
which characterizes sickle cell anaemia. It also 
established that these effects of oxidant drugs on 
sickle erythrocytes are not significantly reduced by 
the two antioxidants tried – ascorbic acid and α - 
tocopherol. Until a more effective free radical 
scavenger is found however, it is advised, based on 
the results of this study, to constantly maintain 
sickle cell patients on a regular supply of α - 
tocopherol, the more effective of the two 
antioxidants tried in this study.          
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